Sight Sciences Announces Long-Term Safety and Effectiveness Data of Standalone Use of the OMNI® Surgical System in Patients with Open Angle Glaucoma
August 16, 2022 08:01 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to...
Sight Sciences Reports Second Quarter 2022 Financial Results
August 11, 2022 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences to Report Second Quarter 2022 Financial Results on August 11, 2022
July 28, 2022 08:00 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences Announces the Appointment of Tamara Fountain, M.D. to its Board of Directors
July 19, 2022 16:26 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences’ OMNI® Surgical System Reduces IOP, Daily Fluctuations in IOP and Medication Use, as Shown in Newly Published 12-Month Clinical Data
May 31, 2022 08:00 ET
|
Sight Sciences, Inc.
Suppression of diurnal, or daily, fluctuations in IOP, is a significant and independent risk factor for the progression of glaucomaThese 12-month outcomes were also confirmed by results from a subset...
Sight Sciences to Present at the Upcoming Piper Sandler Virtual Ophthalmology & Diabetes Symposium
May 19, 2022 08:00 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and improve...
Sight Sciences Reports First Quarter 2022 Financial Results
May 10, 2022 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
April 29, 2022 08:00 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences Announces Multiple Presentations and Event at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting
April 20, 2022 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...
Sight Sciences to Report First Quarter 2022 Financial Results on May 10, 2022
April 14, 2022 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and...